AAAAAA

   
Results: 1-24 |
Results: 24

Authors: Babiker, A Darbyshire, N Pezzotti, P Porter, K Rezza, G Walker, S Beral, V Coutinho, R Del Amo, J Gill, N Lee, C Meyer, L Tyrer, F Dabis, F Thiebaut, R Lawson-Ayayi, S Meyer, L Boufassa, F Hamouda, O Lorenzo, JI Touloumi, G Hatzakis, A Karafoulidou, A Katsarou, O Brettle, R del Romero, J Prins, M Coutinho, RA van Benthem, B Coutinho, RA Kirk, O Pedersen, C Aguado, IH Perez-Hoyos, S Eskild, A Bruun, JN Sannes, M Sabin, C Johnson, AM Phillips, AN Darbyshire, JH Francioli, P Vanhems, P Egger, M Rickenbach, M Cooper, D Kaldor, J Vizzard, J Tusell, JM Ruiz, I Cayla, JA de Olalla, PG Day, NE De Angelis, D
Citation: A. Babiker et al., Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?, J ACQ IMM D, 28(2), 2001, pp. 158-165

Authors: Husum, TL Jorgensen, CT Christensen, MW Kirk, O
Citation: Tl. Husum et al., Enzyme catalysed synthesis in ambient temperature ionic liquids, BIOCATAL B, 19(4), 2001, pp. 331-338

Authors: Kirk, O Glenthoj, J Dragsted, UB Helweg-Larsen, J Aru, TM Benfield, TL Jensen, K Vestbo, J Lundgren, JD
Citation: O. Kirk et al., Penicillin as empirical therapy for patients hospitalised with community acquired pneumonia at a Danish hospital, DAN MED B, 48(2), 2001, pp. 84-88

Authors: Kirk, O Mocroft, A Pradier, C Bruun, JN Hemmer, R Clotet, B Miller, V Viard, JP Phillips, AN Lundgren, JD
Citation: O. Kirk et al., Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir, AIDS, 15(8), 2001, pp. 999-1008

Authors: Phillips, AN Staszewski, S Weber, R Kirk, O Francioli, P Miller, V Vernazza, P Lundgren, JD Ledergerber, B
Citation: An. Phillips et al., HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load, J AM MED A, 286(20), 2001, pp. 2560-2567

Authors: Ledergerber, B Mocroft, A Reiss, P Furrer, H Kirk, O Bickel, M Uberti-Foppa, C Pradier, C Monforte, AD Schneider, MME Lundgren, JD
Citation: B. Ledergerber et al., Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy., N ENG J MED, 344(3), 2001, pp. 168-174

Authors: Viard, JP Mocroft, A Chiesi, A Kirk, O Roge, B Panos, G Vetter, N Bruun, JN Johnson, M Lundgren, JD
Citation: Jp. Viard et al., Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: Evidence fromthe EuroSIDA study, J INFEC DIS, 183(8), 2001, pp. 1290-1294

Authors: Kirk, O Pedersen, C Cozzi-Lepri, A Antunes, F Miller, V Gatell, JM Katlama, C Lazzarin, A Skinhoj, P Barton, SE
Citation: O. Kirk et al., Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy, BLOOD, 98(12), 2001, pp. 3406-3412

Authors: Kirk, O Gatell, JM Mocroft, A Pedersen, C Proenca, R Brettle, RP Barton, SE Sudre, P Phillips, AN Lundgren, JD
Citation: O. Kirk et al., Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviraltherapy, AM J R CRIT, 162(3), 2000, pp. 865-872

Authors: Blaxhult, A Kirk, O Pedersen, C Dietrich, M Barton, SE Gatell, JM Mulcahy, F Hirschel, B Mocroft, A Lundgren, JD
Citation: A. Blaxhult et al., Regional differences in presentation of AIDS in Europe, EPIDEM INFE, 125(1), 2000, pp. 143-151

Authors: Hansen, PB Penkowa, M Kirk, O Skinhoj, P Pedersen, C Lisse, I Kiss, K Zhou, XG Hamilton-Dutoit, SJ
Citation: Pb. Hansen et al., Human immunodeficiency virus-associated malignant lymphoma in eastern Denmark diagnosed from 1990 to 1996: clinical features, histopathology, and association with Epstein-Barr virus and human herpesvirus-8, EUR J HAEMA, 64(6), 2000, pp. 368-375

Authors: Porter, K Babiker, A Walker, S Darbyshire, J Gill, N Beral, V Coutinho, R Darbyshire, J Gill, N Lee, C Meyer, L Rezza, G Porter, K Babiker, A Walker, S Darbyshire, J Tyrer, F Dabis, F Marimoutou, C Meyer, L Boufassa, F Hamouda, O Brunn, M Pezzotti, P Rezza, G Lorenzo, JI Touloumi, G Hatzakis, A Karafoulidou, A Katsarou, O Brettle, R Del Amo, J del Romero, J Prins, M Coutinho, RA van Benthem, B Coutinho, RA Kirk, O Pedersen, C AGuado, IH Perez-Hoyos, S Eskild, A Bruun, JN Sannes, M Sabin, C Lee, C Johnson, AM Phillips, AN Babiker, A Darbyshire, JH Gill, N Porter, K Egger, M Francioli, P Rickenbach, M Cooper, D Kaldor, J Cooper, D Kaldor, J Vizzard, J Tusell, JM Ruiz, I Cayla, JA de Olalla, PG Day, NE De Angelis, D
Citation: K. Porter et al., Effect of ignoring the time of HIV seroconversion in estimating changes insurvival over calendar time in observational studies: results from CASCADE, AIDS, 14(13), 2000, pp. 1899-1906

Authors: Mocroft, A Katlama, C Johnson, AM Pradier, C Antunes, F Mulcahy, F Chiesi, A Phillips, AN Kirk, O Lundgren, JD
Citation: A. Mocroft et al., AIDS across Europe, 1994-98: the EuroSIDA study, LANCET, 356(9226), 2000, pp. 291-296

Authors: Babiker, A Darby, S De Angelis, D Kwart, D Porter, K Beral, V Darbyshire, J Day, N Gill, N Coutinho, R Prins, M van Benthem, B Coutinho, R Dabis, F Marimoutou, C Ruiz, I Tusell, J Altisent, C Evatt, B Jaffe, H Kirk, O Pedersen, C Rosenberg, P Goedert, J Biggar, R Melbye, M Brettie, R Downs, A Hamouda, O Touloumi, G Karafoulidou, A Katsarou, O Donfield, S Gomperts, E Hilgartner, M Hoots, K Schoenbaum, E Beral, V Zangerle, R Del Amo, J Pezzotti, P Rezza, G Hutchinson, S Day, N De Angelis, D Gore, S Kingsley, L Schrager, L Rosenberg, P Goedert, J Melnick, S Koblin, B Eskild, A Bruun, J Sannes, M Evans, B Lepri, AC Sabin, C Buchbinder, S Vittinghoff, E Moss, A Osmond, D Winkelstein, W Goldberg, D Boufassa, F Meyer, L Egger, M Francioli, P Rickenbach, M Cooper, D Tindall, B Sharkey, T Vizzard, J Kaldor, J Cunningham, P Vanhems, P Vizzard, J Kaldor, J Learmont, J Farewell, V Berglund, O Mosley, J Operskalski, E van den Berg, M Metzger, D Tobin, D Woody, G Rusnak, J Hendrix, C Garner, R Hawkes, C Renzullo, P Garland, F Darby, S Ewart, D Giangrande, P Lee, C Phillips, A Spooner, R Wilde, J Winter, M Babiker, A Darbyshire, J Evans, B Gill, N Johnson, A Phillips, A Porter, K Lorenzo, JI Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137

Authors: Katzenstein, TL Kirk, O Pedersen, C Lundgren, JD Nielsen, H Obel, N Nielsen, C Mathiesen, LR Gerstoft, J
Citation: Tl. Katzenstein et al., The Danish protease inhibitor study: A randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection, J INFEC DIS, 182(3), 2000, pp. 744-750

Authors: Paredes, R Mocroft, A Kirk, O Lazzarin, A Barton, SE van Lunzen, J Katzenstein, TL Antunes, F Lundgren, JD Clotet, B
Citation: R. Paredes et al., Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe - Results fromthe EuroSIDA Study, ARCH IN MED, 160(8), 2000, pp. 1123-1132

Authors: Kirk, O Conrad, LS
Citation: O. Kirk et Ls. Conrad, Metal-free haloperoxidases: Fact or artifact?, ANGEW CHEM, 38(7), 1999, pp. 977-979

Authors: Mocroft, A Kirk, O Barton, SE Dietrich, M Proenca, R Colebunders, R Pradier, C Monforte, AD Ledergerber, B Lundgren, JD
Citation: A. Mocroft et al., Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe, AIDS, 13(8), 1999, pp. 943-950

Authors: Kirk, O Lundgren, JD Pedersen, C Nielsen, H Gerstoft, J
Citation: O. Kirk et al., Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?, AIDS, 13(13), 1999, pp. 1647-1651

Authors: Kirk, O Katzenstein, TL Gerstoft, J Mathiesen, L Nielsen, H Pedersen, C Lundgren, JD
Citation: O. Kirk et al., Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial, AIDS, 13(1), 1999, pp. F9-F16

Authors: Weverling, GJ Mocroft, A Ledergerber, B Kirk, O Gonzalez-Lahoz, J Monforte, AD Proenca, R Phillips, AN Lundgren, JD Reiss, P
Citation: Gj. Weverling et al., Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection, LANCET, 353(9161), 1999, pp. 1293-1298

Authors: Jensen-Fangel, S Kirk, O Larsen, L Blaxhult, A Gerstoft, J Pedersen, C Black, FT Lundgren, JD Obel, N
Citation: S. Jensen-fangel et al., Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: A retrospective cohort study, SC J IN DIS, 31(5), 1999, pp. 489-493

Authors: Nielsen, TB Ishii, M Kirk, O
Citation: Tb. Nielsen et al., Lipases A and B from the yeast Candida antarctica, BIOTECHNOLOGICAL APPLICATIONS OF COLD-ADAPTED ORGANISMS, 1999, pp. 49-61

Authors: Benfield, TL Kirk, O Elbrond, B Pedersen, C
Citation: Tl. Benfield et al., Complete histological regression of Kaposi's sarcoma following treatment with protease inhibitors despite persistence of HHV-8 in lesions, SC J IN DIS, 30(6), 1998, pp. 613-615
Risultati: 1-24 |